Enhanced Ocular Delivery Systems and Methods

Improved ocular delivery systems and methods for accessing Schlemm's canal, delivering viscoelastic fluid compositions, and performing trabeculotomies, featuring advanced micro-robotic navigation, ultrasound-based sensing, customized fluid compositions, and real-time ocular pressure monitoring.

The original patent disclosed systems and methods for accessing Schlemm's canal, delivering fluid compositions, and performing trabeculotomies. However, these systems and methods had limitations, including the potential for tissue disruption and variability in fluid delivery. The new inventive concept addresses these limitations by introducing advanced technologies and features that improve the safety, efficacy, and customization of ocular delivery systems and methods.

The enhanced ocular delivery systems and methods comprise a micro-robotic component that navigates through Schlemm's canal to deliver a viscoelastic fluid composition, minimizing tissue disruption and adapting to the canal's geometry. The systems also feature an ultrasound-based sensing system to identify optimal sites for fluid delivery and tissue disruption, increasing the efficacy of the procedure. Additionally, the systems can deliver customized fluid compositions tailored to a patient's specific ocular anatomy, and provide real-time monitoring of ocular pressure during the procedure. The micro-robotic component can be designed to operate in tandem with the ultrasound-based sensing system, ensuring precise and controlled delivery of the fluid composition.

The new inventive concept introduces significant advancements over the original patent, including the use of micro-robotic navigation, ultrasound-based sensing, and customized fluid compositions. These features provide a substantial improvement in the safety, efficacy, and customization of ocular delivery systems and methods, making the new inventive concept novel and non-obvious compared to the original patent.

Alternative embodiments of the inventive concept could include the use of other sensing modalities, such as optical coherence tomography (OCT) or fluorescence imaging, to guide the micro-robotic component. Additionally, the customized fluid compositions could be tailored to specific disease states or patient populations, and the real-time ocular pressure monitoring could be integrated with other diagnostic tools to provide a more comprehensive understanding of ocular health.

The enhanced ocular delivery systems and methods have significant commercial potential in the ophthalmology market, particularly in the treatment of glaucoma and other ocular diseases. The systems could be marketed to ophthalmologists, hospitals, and clinics, and could potentially disrupt the existing market for ocular delivery systems and methods.